Brielle Benyon

In this episode of “The Vitals,” an oncology nurse practitioner and certified yoga instructor discusses simple mindfulness strategies that can improve resiliency, leading to fewer feelings of clinician burnout.

While some patients are the exception, most should get vaccinated as soon as they are eligible to do so.

The National Comprehensive Cancer Network (NCCN) recently issued guidance on treating patients who have both a diagnosis of cancer and of COVID-19.

In the era of COVID-19, building resiliency and reducing burnout are key goals for many oncology nurses. Mindfulness and yoga can help.

Many nurses are overworked and burnt out, but changes in health policy may be a step toward making things better. One expert explains how.

While nurse burnout is common, there are steps that nurses can take to improve their resiliency and live healthier, happier lives.

Baseline fatigue levels, prior psychosocial history, and cancer treatment may all affect the fatigue trajectory in women with breast cancer.

Certain patient characteristics correlated with a higher rate of fear of cancer recurrence.

This is the third COVID-19 vaccine to be granted emergency use authorization, and is the first single-dose vaccine.

The FDA approved melphalan flufenamide (Pepaxto; melflufen) plus dexamethasone for adults with triple-refractory multiple myeloma.

The FDA approved single-agent frontline cemiplimab-rwlc (Libtayo) for the treatment of patients with advanced non-small cell lung cancer (NSCLC) with a PD-L1 expression of 50% or greater.

Fear of cancer recurrence is a common plight for people after they have completed cancer treatment, and recent research analyzed which patient characteristics were associated with higher rates of fear of recurrence.

Parents of pediatric patients with cancer were more likely to believe COVID-19 misinformation than parents of children without cancer.

Patients with metastatic urothelial carcinoma with higher tumor mutational burden and who experienced immune-related adverse events tended to have higher response rates to immune checkpoint inhibitor.

The COVID-19 pandemic increased rates of stress in the general public, adding to that of survivors who may already be feeling anxious.

The FDA approved umbralisib (Ukoniq) for the treatment of adults with relapsed/refractory marginal zone lymphoma (MZL) who had at least 1 prior anti-CD20—based regimen; and adults with relapsed/refractory follicular lymphoma (FL) who had at least 3 prior lines of systemic therapy.

Testicular cancer survivors had a higher rate of mental health service utilization than their healthy counterparts.

Hear from other oncology nurses on what their career means to them, and how they overcame challenges in the last year.

The FDA approved tepotinib (Tepmetko) for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) with MET exon 14-skipping alterations, according to the FDA.

A recent study found that 19% of patients with cancer engaged in nonmedical opioid use.

A virtual prehabilitaiton program improved patient outcomes before they underwent lung cancer surgery.

Patients with non-small cell lung cancer (NSCLC) who experience immune-related adverse events (irAEs) may have better survival outcomes than those without irAEs.

We gathered content on COVID-19 vaccination, and what it means for oncology nurses and the patients they treat.

Nearly 20% of patients with cancer engaged in nonmedical opioid use, but oncology nurses can help prevent this from happening.

The FDA approved cabozantinib (Cabometyx) plus nivolumab (Opdivo) for the frontline treatment of patients with advanced renal cell carcinoma (RCC).

The National Comprehensive Cancer Network (NCCN) today release guidance for COVID-19 vaccinations in patients with cancer.

Findings of an epidemiological study show that regular aspirin use could boost survival in older patients with breast and bladder cancers, but more research is still needed.

Vaccine rollout continues to be slow, so social distancing and mask wearing should remain common practice, nurses say.

We spoke with a group of oncology nurses about the questions that patients are asking regarding the COVID-19 vaccine.